mecamylamine has been researched along with Cancer of Colon in 2 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Still, PC | 1 |
Yi, B | 1 |
González-Cestari, TF | 1 |
Pan, L | 1 |
Pavlovicz, RE | 1 |
Chai, HB | 1 |
Ninh, TN | 1 |
Li, C | 1 |
Soejarto, DD | 1 |
McKay, DB | 1 |
Kinghorn, AD | 1 |
Kikuchi, H | 1 |
Itoh, J | 1 |
Fukuda, S | 1 |
2 other studies available for mecamylamine and Cancer of Colon
Article | Year |
---|---|
Alkaloids from Microcos paniculata with cytotoxic and nicotinic receptor antagonistic activities.
Topics: Alkaloids; Bridged Bicyclo Compounds, Heterocyclic; Colonic Neoplasms; HT29 Cells; Humans; Malvaceae | 2013 |
Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor.
Topics: Aged; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; GATA3 Transcription Factor; Human | 2008 |